Gene · 2285
FKBP1AP4: FKBP prolyl isomerase 1A pseudogene 4
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. FKBP1AP4: FKBP prolyl isomerase 1A pseudogene 4. Genes, record 2285. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2285
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,879
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FKBP1AP4 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| R35CA197589 | Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities | 7 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 6 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| ZIAHD000196 | Phosphoinositide-calcium Signaling In Cell Regulation | 6 | 2025 |
| R01CA240981 | Harnessing E3 Ligases for Cancer Therapy | 5 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
1 to 10 of 1,879Source NIH's project files
See all 1,879 nih grantsPapers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Versatile DNA-Encoded Library Platform for the Discovery of Highly Cooperative Chemical Inducers of Proximity. | Adv Sci (Weinh) | 2026 | 42801576 | PubTator, text mining | PubMed |
| Cell type-selective targeting by heterobifunctional protein binders via in-cell enrichment. | Nat Commun | 2026 | 42754590 | PubTator, text mining | PubMed |
| Quantitative correlation of spectroscopic signatures with ligand-protein interactions in anti-cancer drug Afinitor: an integrated experimental-computational study. | Sci Rep | 2026 | 42493535 | PubTator, text mining | PubMed |
| High-throughput ligand discovery in living cells using the cellular protein stability enhancement assay. | Acta Pharm Sin B | 2026 | 42453421 | PubTator, text mining | PubMed |
| The NanoBridge system for targeted post-translational modification of challenging proteins. | bioRxiv | 2026 | 42327206 | PubTator, text mining | PubMed |
| Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation. | Mol Ther Adv | 2026 | 42147444 | PubTator, text mining | PubMed |
| Protocol for the generation of DDT signaling reporter cell line for CRISPR screening. | STAR Protoc | 2026 | 42033729 | PubTator, text mining | PubMed |
| Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries. | Nat Commun | 2026 | 42020383 | PubTator, text mining | PubMed |
| Engineering Rapamycin-Induced Dimerization for Control of Gene Expression in Plants. | ACS Synth Biol | 2026 | 41990133 | PubTator, text mining | PubMed |
| Harnessing FBXO31 with Terminal Amide-Functionalized Molecules for Targeted Protein Degradation. | J Am Chem Soc | 2026 | 41963263 | PubTator, text mining | PubMed |
1 to 10 of 2,250
See all 2,250 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2285
GET https://conductscience.org/api/genes/v1/2285/grants?page=2